JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v54,p575)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Morré, S A
Right arrow Articles by Niessen, H W M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Morré, S A
Right arrow Articles by Niessen, H W M
J Clin Pathol 2000; 53:647-654
© 2000 Journal of Clinical Pathology


Leader

Microorganisms in the aetiology of atherosclerosis

S A Morré1, W Stooker2, W K Lagrand3, A J C van den Brule1, H W M Niessen1

1 Department of Pathology, University Hospital Vrije Universiteit, PO Box 7057, De Boelelaan 1117, 1007 MB Amsterdam, The Netherlands
2 Department of Cardiac Surgery, University Hospital Vrije Universiteit
3 Department of Cardiology, University Hospital Vrije Universiteit

Dr Niessen email: jwm.niessen{at}azvu.nl Recent publications have suggested that infective pathogens might play an important role in the pathogenesis of atherosclerosis. This review focuses on these microorganisms in the process of atherosclerosis. The results of in vitro studies, animal studies, tissue studies, and serological studies will be summarised, followed by an overall conclusion concerning the strength of the association of the microorganism with the pathogenesis of atherosclerosis. The role of the bacteria Chlamydia pneumoniae and Helicobacter pylori, and the viruses human immunodeficiency virus, coxsackie B virus, cytomegalovirus, Epstein-Barr virus, herpes simplex virus, and measles virus will be discussed.

Key Words: atherosclerosis • Chlamydia pneumoniaeHelicobacter pylori




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
M. Bukrinsky and D. Sviridov
Human immunodeficiency virus infection and macrophage cholesterol metabolism.
J. Leukoc. Biol., November 1, 2006; 80(5): 1044 - 1051.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. W.M Niessen, P. A.J Krijnen, C. A Visser, C. J.L.M Meijer, and C Erik Hack
Type II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?
Cardiovasc Res, October 15, 2003; 60(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. J de Boer, A. E Becker, and A. C van der Wal
T lymphocytes in atherogenesis--functional aspects and antigenic repertoire
Cardiovasc Res, October 15, 2003; 60(1): 78 - 86.
[Full Text] [PDF]


Home page
CirculationHome page
J. Oh, R. Wunsch, M. Turzer, M. Bahner, P. Raggi, U. Querfeld, O. Mehls, and F. Schaefer
Advanced Coronary and Carotid Arteriopathy in Young Adults With Childhood-Onset Chronic Renal Failure
Circulation, July 2, 2002; 106(1): 100 - 105.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. G. Alber, P. Vallance, and K. L. Powell
Enhanced Atherogenesis Is Not an Obligatory Response to Systemic Herpesvirus Infection in the ApoE-Deficient Mouse: Comparison of Murine {gamma}-Herpesvirus-68 and Herpes Simplex Virus-1
Arterioscler. Thromb. Vasc. Biol., May 1, 2002; 22(5): 793 - 798.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
D Taylor-Robinson, B J Thomas, R Goldin, and R Stanbridge
Chlamydia pneumoniae in infrequently examined blood vessels
J. Clin. Pathol., March 1, 2002; 55(3): 218 - 220.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
E. Fosslien
Mitochondrial Medicine - Molecular Pathology of Defective Oxidative Phosphorylation
Ann. Clin. Lab. Sci., January 1, 2001; 31(1): 25 - 67.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.